Clinical Trials List
2020-10-01 - 2025-12-31
Phase III
Not yet recruiting7
Recruiting1
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ya-Ting Hsu Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Kuo-Ting Lee Division of General Surgery
- Ya-Ping Chen Division of Hematology & Oncology
- Yao-Lung Kuo Division of General Surgery
- 楊舜如 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 馮晉榮 Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- 林燕淑 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 邱仁輝 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 賴亦貞 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chih-Jung Chen Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Yao-Chung Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 陳怡君 Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
- 張端瑩 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- Wei-Wu Chen Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- 林季宏 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 甘蓉瑜 Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 巫承哲 Division of General Surgery
- Fu Ouyang Division of General Surgery
- Fang-Ming Chen Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Shen Liang Shih Division of General Surgery
- 高捷妮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 沈士哲 Division of General Surgery
- Yung-Chang Lin Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- Mengting Peng Division of Hematology & Oncology
- Shin-Cheh Chen Division of General Surgery
- 周旭桓 Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
- 陳訓轍 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 于承平 Division of Others
- 張平穎 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
330 participants
